209 related articles for article (PubMed ID: 31208832)
1. Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.
Klimek K; Aresté Fosalba N; Ramírez López MÁ; Gómez Castilla AC; Salgueira Lazo M
Nefrologia (Engl Ed); 2020; 40(2):197-201. PubMed ID: 31208832
[TBL] [Abstract][Full Text] [Related]
2. Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.
Sosa Barrios RH; Álvarez Nadal M; Burguera Vion V; Campillo Trapero C; López Melero E; Fernández Lucas M; Rivera Gorrín ME
J Vasc Access; 2021 Mar; 22(2):261-265. PubMed ID: 32605474
[TBL] [Abstract][Full Text] [Related]
3. Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Gallieni M; Chiarelli G; Olivi L; Cozzolino M; Cusi D
Clin Nephrol; 2011 Jan; 75(1):70-3. PubMed ID: 21176753
[TBL] [Abstract][Full Text] [Related]
4. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
[TBL] [Abstract][Full Text] [Related]
5. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
Hansson JH
Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410
[No Abstract] [Full Text] [Related]
6. Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.
Oguz H; Zeyrek FY; Ozardali I; Oguz E; Gurkan T
Curr Eye Res; 2004 Apr; 28(4):225-32. PubMed ID: 15259291
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
Cavanagh JP; Granslo HN; Fredheim EA; Christophersen L; Jensen PØ; Thomsen K; Van Gennip M; Klingenberg C; Flaegstad T; Moser C
J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
Luther MK; Mermel LA; LaPlante KL
J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.
Lew SQ; Gruia A
Perit Dial Int; 2013; 33(1):101-2. PubMed ID: 23349200
[No Abstract] [Full Text] [Related]
11. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis.
Schneider A; Sack U; Rothe K; Bennek J
Pediatr Surg Int; 2005 Jun; 21(6):445-8. PubMed ID: 15902475
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin in peritoneal dialysis, intraperitoneal or intravenous.
Pérez Melón C; Borrajo Prol M; Iglesias E; Ferreiro B; Camba Caride M
Nefrologia; 2016; 36(4):461-2. PubMed ID: 26680497
[No Abstract] [Full Text] [Related]
13. Staphylococcus aureus peritonitis in two peritoneal dialysis patients: an uncommon complication of peripheral intravenous catheter infection.
Ma MK; Yap DY; Yip TP; Lui SL; Lo WK
Perit Dial Int; 2012; 32(5):573-4. PubMed ID: 22991021
[No Abstract] [Full Text] [Related]
14. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
15. Fulminant peritonitis presumably caused by Panton-Valentine leukocidin-positive Staphylococcus aureus in a girl on peritoneal dialysis.
Battelino N; Pokorn M; Švent-Kučina N; Križan-Hergouth V; Novljan G
Ther Apher Dial; 2013 Aug; 17(4):431-7. PubMed ID: 23931885
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal Dialysis-Related Peritonitis: Atypical and Resistant Organisms.
Cho Y; Struijk DG
Semin Nephrol; 2017 Jan; 37(1):66-76. PubMed ID: 28153196
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis.
Alvarez Nadal M; Sosa Barrios RH; Burguera Vion V; Campillo Trapero C; Fernández Lucas M; Rivera Gorrín ME
Kidney Med; 2020; 2(5):650-651. PubMed ID: 33089141
[TBL] [Abstract][Full Text] [Related]
18. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
[TBL] [Abstract][Full Text] [Related]
19. Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar.
Shigidi MM; Fituri OM; Chandy SK; Asim M; Al Malki HA; Rashed AH
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):168-73. PubMed ID: 20061719
[TBL] [Abstract][Full Text] [Related]
20.
Carvalho TJ; Branco PQ; Martins AR; Gaspar A
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
